Abstract: Systems and methods for tracking and evaluating fuel consumptions of vehicles are provided. The method can involve operating a telematics device installed in the vehicle to: collect fuel data from at least one fuel data source of the vehicle; track, for each fuel data source, a cumulative amount of fuel consumed by the vehicle; determine a confidence level of each fuel data source; identify an initial fuel data source; generate a plurality of mid-trip fuel records; identify a final fuel data source based on a priority of each fuel data source and each confidence level of each fuel data source; determine whether the plurality of mid-trip fuel records is valid; and transmit the plurality of mid-trip fuel records and an indication of whether the plurality of mid-trip fuel records is valid to a fleet management system.

Abstract: A wearable haptic navigation system for obscured visibility environments, the wearable haptic navigation system including: a wearable haptic component, in one alternative a body covering suite; and a mapping data collector and processor in communication with the wearable haptic component; wherein the mapping data collector and processor collects data related to a path traversed by a user of the wearable haptic navigation system and generates at least one proprioception suggestion signal to the wearable haptic component providing the user with a suggested safe egress path and/or a suggested safe body position.

Abstract: Disclosed herein are systems and methods for query processing with restrictions in a database clean room. In an embodiment, a system receives a query directed to a combination of a first source dataset from a first database account of a distributed database and a second source dataset from a second database account of the distributed database. The system generates an approved statements table that contains database statement language that can be executed against the combination of the first and second source datasets. Based on determining that the approved statements table includes the query, the system executes the query to produce results data, and stores the results data in the first database account.

Abstract: The invention is a monitoring device for use in composting comprising a system controller, a wireless communication controller, at least one sensor, a rechargeable power cell and a recharging means, with a power consumption rate of less than 0.50 W-hrs/day. The invention includes a method of using the compost monitoring device in conjunction with a receiving device that includes suitable algorithms to interpret the sensor data to provide a user with recommended actions for maintaining the compost.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: Methods of formulating live biotherapeutics are disclosed in which a deficiency or excess of a specific bacterial strain in a person's microbiome is identified by comparing a gene-specific characterization of the person's microbiome against a comprehensive, non-redundant reference gene catalog, and the biotherapeutic is formulated by selecting bacteria to address the deficiency or excess. Embodiments include the formulation of live biotherapeutics for improving the health of a person's vaginal microbiome, i.e. using a vaginal reference gene catalog, and may be suitable for ameliorating, treating, or preventing a malignancy such as a cancer of the female genitourinary system.

Abstract: An automatic door opener for delivery trucks may include a door opener motor, clutch, and transmission which are connected to a door opener rail. The automatic door opener is attached to the roof of a delivery truck cargo bay and the door opener motor is operable to open and close a cargo door. The clutch and motor are controlled by a motor control computer which may be programmed to automatically operate the clutch, close the cargo bay door, and disengage the clutch as desired. A rail carriage may be connected to the cargo bay door by a door connector arm which includes a quick release connection to the carriage and which may be operated from the outside of the cargo bay door. A sensor may be connected to the door opener rail and to the motor control computer such that the motor control computer tracks the position of the carriage along the door opener rail independent of the operation of the motor.

Abstract: An automatic door opener for delivery trucks may include a door opener motor, clutch, and transmission which are connected to a door opener rail. The automatic door opener is attached to the roof of a delivery truck cargo bay and the door opener motor is operable to open and close a cargo door. The clutch and motor are controlled by a motor control computer which may be programmed to automatically operate the clutch, close the cargo bay door, and disengage the clutch as desired. A rail carriage may be connected to the cargo bay door by a door connector arm which includes a quick release connection to the carriage and which may be operated from the outside of the cargo bay door. A sensor may be connected to the door opener rail and to the motor control computer such that the motor control computer tracks the position of the carriage along the door opener rail independent of the operation of the motor.

Abstract: An automatic door opener for delivery trucks may include a door opener motor, clutch, and transmission which are connected to a door opener rail. The automatic door opener is attached to the roof of a delivery truck cargo bay and the door opener motor is operable to open and close a cargo door. The clutch and motor are controlled by a motor control computer which may be programmed to automatically operate the clutch, close the cargo bay door, and disengage the clutch as desired. A rail carriage may be connected to the cargo bay door by a door connector arm which includes a quick release connection to the carriage and which may be operated from the outside of the cargo bay door. A sensor may be connected to the door opener rail and to the motor control computer such that the motor control computer tracks the position of the carriage along the door opener rail independent of the operation of the motor.

Abstract: An alloy casting having a protective layer disposed on a surface of the casting is provided. The protective layer is resistant to liquid metal attack, and wherein the protective layer includes an oxide of an element present in the alloy. A method of forming a protective layer on a surface of the alloy casting is also provided. The method includes disposing the alloy in a mold, and oxidizing an element of the alloy to form a protective layer on the surface of the casting.

Abstract: An alloy casting having a protective layer disposed on a surface of the casting is provided. The protective layer is resistant to liquid metal attack, and wherein the protective layer includes an oxide of an element present in the alloy. A method of forming a protective layer on a surface of the alloy casting is also provided. The method includes disposing the alloy in a mold, and oxidizing an element of the alloy to form a protective layer on the surface of the casting.

Abstract: In one embodiment, a method is provided for measuring a dynamic phase offset between a PLL's input clock and the PLL's feedback input clock, wherein the input clock is spread spectrum modulated in a spread spectrum mode and is not modulated in a static mode. The method includes: in the spread spectrum mode, measuring phase jitter between the input clock and the feedback input clock to form a spread spectrum phase jitter measurement; in the static mode, measuring phase jitter between the input clock and the feedback input clock to form a static phase jitter measurement; and comparing the spread spectrum phase jitter measurement to the static phase jitter measurement to determine the dynamic phase offset.

Abstract: In accordance with one or more embodiments of the present invention, a system includes a phase-locked loop circuit that receives a reference signal and a feedback signal and provides an output signal. A control circuit also receives the reference signal and the feedback signal and provides a correction current for the phase-locked loop circuit to reduce a phase error of the output signal.